USARx offers the following ways to purchase this medication. Choose the Best option for you!
Pay this amount and pick up your prescription at ANY Retail pharmacy of your choice! Walgreens, CVS, Walmart, etc.
The easiest way to receive your medications.
No38% of Medicare Part D and Medicare Advantage plans cover this drug, so it's pretty much a toss-up.
It depends. Which coverage stage are you in? Click on a tab below…
$15 – $2416
In the Deductible co-pay stage, you are responsible for the full cost of your prescriptions. Your Medicare deductible cannot exceed $360 in 2016.
Here are some ways that may lower the cost of your methyltestosterone prescription.
If your Medicare co-pay is higher, you can save money by using a USARx coupon instead.
Applies to methyltestosterone: oral capsules, oral tablets
Side effects include:
Males: Gynecomastia, frequent or persistent penile erections.
Females: Amenorrhea, other menstrual irregularities, inhibition of gonadotropin secretion, virilization (e.g., deepening of the voice, clitoral enlargement).For Healthcare Professionals
Applies to methyltestosterone: compounding powder, oral capsule, oral tabletGeneral
The more commonly reported adverse effects of androgen therapy in males is gynecomastia and excessive frequency and duration of penile erections; in women, virilization including voice deepening and clitoral enlargement.Cardiovascular
Frequency not reported: Edema with or without congestive heart failure, myocardial infarction, stroke
Postmarketing reports: venous thromboembolic events, including deep vein thrombosis (DVT)Endocrine
Frequency not reported: Gynecomastia, virilization (women), hirsutismHepatic
Rare (less than 0.1%): Peliosis hepatic
Frequency not reported: Cholestatic jaundice, altered liver functionGenitourinary
Frequency not reported: Amenorrhea, menstrual irregularities, excessive frequency and duration of penile erections, oligospermia, increased or decreased libidoMetabolic
Frequency not reported: Retention of sodium, chloride, water, potassium, calcium and inorganic phosphates, increased serum cholesterol, hypercalcemiaDermatologic
Frequency not reported: Male pattern baldness, acneGastrointestinal
Frequency not reported: Nausea, vomitingMusculoskeletal
Frequency not reported: acceleration of bone maturation without producing compensatory gain in linear growth resulting in compromised adult statureHematologic
Frequency not reported: Suppression of clotting factors II, V, VII, and X; bleeding (in patients on concomitant anticoagulant therapy and polycythemia)Hypersensitivity
Very rare (less than 0.01%): Anaphylactoid reactionsNervous system
Frequency not reported: Headache, generalized paresthesiaOncologic
Rare (less than 0.1%): Hepatocellular neoplasmsRespiratory
Postmarketing reports: venous thromboembolic events, including pulmonary embolismPsychiatric
Frequency not reported: Steroid abuse, anxiety, depression
December 16, 2020
March 1, 2021
February 15, 2021
March 1, 2021
February 1, 2021
January 31, 2021